PCV45 COST-UTILITY ANALYSIS OF RIMONABANT IN THE MANAGEMENT OF OBESITY/OVERWEIGHT PATIENTS WITH CARDIOMETABOLIC RISK FACTORS IN HUNGARY
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65460-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)65460-5/fulltext
Section Title :
Section Order :
619
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65460-5&doi=10.1016/S1098-3015(10)65460-5